<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33892821</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>23</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>Combined epigenetic/genetic study identified an ALS age of onset modifier.</ArticleTitle><Pagination><StartPage>75</StartPage><MedlinePgn>75</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">75</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-021-01183-w</ELocationID><Abstract><AbstractText>Age at onset of amyotrophic lateral sclerosis (ALS) is highly variable (eg, 27-74&#xa0;years in carriers of the G<sub>4</sub>C<sub>2</sub>-expansion in C9orf72). It might be influenced by environmental and genetic factors via the modulation of DNA methylation (DNAm) at CpG-sites. Hence, we combined an epigenetic and genetic approach to test the hypothesis that some common single nucleotide polymorphisms (SNPs) at CpG-sites (CpG-SNPs) could modify ALS age of onset. Our genome-wide DNAm analysis suggested three CpG-SNPs whose DNAm levels are significantly associated with age of onset in 249 ALS patients (q&#x2009;&lt;&#x2009;0.05). Next, genetic analysis validated the association of rs4970944 with age of onset in the discovery (n&#x2009;=&#x2009;469; P&#x2009;=&#x2009;0.025) and replication (n&#x2009;=&#x2009;4160; P&#x2009;=&#x2009;0.007) ALS cohorts. A meta-analysis of the cohorts combined showed that the median onset in AA-carriers is two years later than in GG-carriers (n&#x2009;=&#x2009;4629; P&#x2009;=&#x2009;0.0012). A similar association was observed with its tagging SNPs, implicating a 16&#xa0;Kb region at the 1q21.3 locus as a modifier of ALS age of onset. Notably, rs4970944 genotypes are also associated with age of onset in C9orf72-carriers (n&#x2009;=&#x2009;333; P&#x2009;=&#x2009;0.025), suggesting that each A-allele delays onset by 1.6&#xa0;years. Analysis of Genotype-Tissue Expression data revealed that the protective A-allele is linked with the reduced expression of CTSS in cerebellum (P&#x2009;=&#x2009;0.00018), which is a critical brain region in the distributed neural circuits subserving motor control. CTSS encodes cathepsin S protein playing a key role in antigen presentation. In conclusion, we identified a 16&#xa0;Kb locus tagged by rs4970944 as a modifier of ALS age of onset. Our findings support the role of antigen presenting processes in modulating age of onset of ALS and suggest potential drug targets (eg, CTSS). Future replication studies are encouraged to validate the link between the locus tagged by rs4970944 and age of onset in independent ALS cohorts, including different ethnic groups.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Shanghai First Rehabilitation Hospital, School of Medicine, Tongji University, Shanghai, 200090, China. mingzhang@tongji.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, 60 Leonard Ave., Toronto, ON, M5T 0S8, Canada. mingzhang@tongji.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Center for Brain and Spinal Cord Research, Tongji University, Shanghai, 200092, China. mingzhang@tongji.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Advanced Study, Tongji University, Shanghai, China. mingzhang@tongji.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xi</LastName><ForeName>Zhengrui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, 60 Leonard Ave., Toronto, ON, M5T 0S8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saez-Atienzar</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chia</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, 60 Leonard Ave., Toronto, ON, M5T 0S8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, 60 Leonard Ave., Toronto, ON, M5T 0S8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montazer Haghighi</LastName><ForeName>Mahdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, 60 Leonard Ave., Toronto, ON, M5T 0S8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traynor</LastName><ForeName>Bryan J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zinman</LastName><ForeName>Lorne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON, M4N 3M5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogaeva</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, 60 Leonard Ave., Toronto, ON, M5T 0S8, Canada. ekaterina.rogaeva@utoronto.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, University of Toronto, Toronto, Canada. ekaterina.rogaeva@utoronto.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z01-AG000949-02</GrantID><Agency>Intramural Research Program of the NIH, National Institute on Aging</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057890" MajorTopicYN="N">Epigenomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Age of onset</Keyword><Keyword MajorTopicYN="N">CpG-SNPs</Keyword><Keyword MajorTopicYN="N">DNA methylation</Keyword><Keyword MajorTopicYN="N">Genetic association</Keyword><Keyword MajorTopicYN="N">Modifier</Keyword></KeywordList><CoiStatement>The authors report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>24</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33892821</ArticleId><ArticleId IdType="pmc">PMC8066440</ArticleId><ArticleId IdType="doi">10.1186/s40478-021-01183-w</ArticleId><ArticleId IdType="pii">10.1186/s40478-021-01183-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andrews SV, Ladd-Acosta C, Feinberg AP, Hansen KD, Fallin MD. "Gap hunting" to characterize clustered probe signals in Illumina methylation array data. Epigenet Chromatin. 2016;9:56. doi: 10.1186/s13072-016-0107-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13072-016-0107-z</ArticleId><ArticleId IdType="pmc">PMC5142147</ArticleId><ArticleId IdType="pubmed">27980682</ArticleId></ArticleIdList></Reference><Reference><Citation>Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, Irizarry RA. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30:1363&#x2013;1369. doi: 10.1093/bioinformatics/btu049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu049</ArticleId><ArticleId IdType="pmc">PMC4016708</ArticleId><ArticleId IdType="pubmed">24478339</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergsma T, Rogaeva E. DNA Methylation clocks and their predictive capacity for aging phenotypes and healthspan. Neurosci Insights. 2020;15:2633105520942221. doi: 10.1177/2633105520942221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2633105520942221</ArticleId><ArticleId IdType="pmc">PMC7376380</ArticleId><ArticleId IdType="pubmed">32743556</ArticleId></ArticleIdList></Reference><Reference><Citation>Berjaoui S, Povedano M, Garcia-Esparcia P, Carmona M, Aso E, Ferrer I. Complex Inflammation mRNA-Related Response in ALS Is Region Dependent. Neural Plast. 2015;2015:573784. doi: 10.1155/2015/573784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/573784</ArticleId><ArticleId IdType="pmc">PMC4537753</ArticleId><ArticleId IdType="pubmed">26301107</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron D El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic Lateral Sclerosis. N Engl J Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36:411&#x2013;420. doi: 10.1038/nbt.4096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.4096</ArticleId><ArticleId IdType="pmc">PMC6700744</ArticleId><ArticleId IdType="pubmed">29608179</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Richard M, Sandler DP, Umbach DM, Kamel F. Head injury and amyotrophic lateral sclerosis. Am J Epidemiol. 2007;166:810&#x2013;816. doi: 10.1093/aje/kwm153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwm153</ArticleId><ArticleId IdType="pmc">PMC2239342</ArticleId><ArticleId IdType="pubmed">17641152</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium GT, Laboratory DA, Coordinating Center -Analysis Working G, Statistical Methods groups-Analysis Working G, Enhancing Gg et al Genetic effects on gene expression across human tissues. Nature. 2017;550:204&#x2013;213. doi: 10.1038/nature24277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24277</ArticleId><ArticleId IdType="pmc">PMC5776756</ArticleId><ArticleId IdType="pubmed">29022597</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Hewitt C, Highley JR, Brockington A, Milano A, Man S, Martindale J, Hartley J, Walsh T, Gelsthorpe C, et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain. 2012;135:751&#x2013;764. doi: 10.1093/brain/awr365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr365</ArticleId><ArticleId IdType="pmc">PMC3286332</ArticleId><ArticleId IdType="pubmed">22366792</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner SD. qqman: an R package for visualizing GWAS results using Q-Q and manhattan plots. J Open Source Softw. 2018 doi: 10.21105/joss.00731.</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.00731</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S, Forer L, Schonherr S, Sidore C, Locke AE, Kwong A, Vrieze SI, Chew EY, Levy S, McGue M, et al. Next-generation genotype imputation service and methods. Nat Genet. 2016;48:1284&#x2013;1287. doi: 10.1038/ng.3656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3656</ArticleId><ArticleId IdType="pmc">PMC5157836</ArticleId><ArticleId IdType="pubmed">27571263</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliano SA, Ptak C, Mak DYF, Shamsi M, Oh G, Knight J, Boutros PC, Petronis A. Allele-Skewed DNA Modification in the Brain: Relevance to a Schizophrenia GWAS. Am J Hum Genet. 2016;98:956&#x2013;962. doi: 10.1016/j.ajhg.2016.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2016.03.006</ArticleId><ArticleId IdType="pmc">PMC4863558</ArticleId><ArticleId IdType="pubmed">27087318</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I, Van Mossevelde S, van der Zee J, Sieben A, Engelborghs S, De Bleecker J, Ivanoiu A, Deryck O, Edbauer D, Zhang M, et al. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol Psychiatry. 2016;21:1112&#x2013;1124. doi: 10.1038/mp.2015.159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.159</ArticleId><ArticleId IdType="pmc">PMC4960451</ArticleId><ArticleId IdType="pubmed">26481318</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannon E, Spiers H, Viana J, Pidsley R, Burrage J, Murphy TM, Troakes C, Turecki G, O'Donovan MC, Schalkwyk LC, et al. Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci. Nat Neurosci. 2016;19:48&#x2013;54. doi: 10.1038/nn.4182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4182</ArticleId><ArticleId IdType="pmc">PMC4714325</ArticleId><ArticleId IdType="pubmed">26619357</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy J, Rogaeva E. Motor neuron disease and frontotemporal dementia sometimes related, sometimes not. Exp Neurol. 2014;262:75&#x2013;83. doi: 10.1016/j.expneurol.2013.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.11.006</ArticleId><ArticleId IdType="pubmed">24246281</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemonnot AL, Hua J, Ulmann L, Hirbec H. Microglia in alzheimer disease: well-known targets and new opportunities. Front Aging Neurosci. 2019;11:233. doi: 10.3389/fnagi.2019.00233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2019.00233</ArticleId><ArticleId IdType="pmc">PMC6730262</ArticleId><ArticleId IdType="pubmed">31543810</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet. 2019;51:414&#x2013;430. doi: 10.1038/s41588-019-0358-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0358-2</ArticleId><ArticleId IdType="pmc">PMC6463297</ArticleId><ArticleId IdType="pubmed">30820047</ArticleId></ArticleIdList></Reference><Reference><Citation>Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O'Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285&#x2013;291. doi: 10.1038/nature19057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19057</ArticleId><ArticleId IdType="pmc">PMC5018207</ArticleId><ArticleId IdType="pubmed">27535533</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim U, Song MA. Dietary and lifestyle factors of DNA methylation. Methods Mol Biol. 2012;863:359&#x2013;376. doi: 10.1007/978-1-61779-612-8_23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-61779-612-8_23</ArticleId><ArticleId IdType="pubmed">22359306</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Arzberger T, Kremmer E, Troost D, Lorenzl S, Mori K, Weng SM, Haass C, Kretzschmar HA, Edbauer D, et al. Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol. 2013;126:859&#x2013;879. doi: 10.1007/s00401-013-1181-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1181-y</ArticleId><ArticleId IdType="pubmed">24096617</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood AR, Teumer A, Kang HM, Fuchsberger C, Danecek P, Sharp K, et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016;48:1279&#x2013;1283. doi: 10.1038/ng.3643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3643</ArticleId><ArticleId IdType="pmc">PMC5388176</ArticleId><ArticleId IdType="pubmed">27548312</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron. 2018;97(1268&#x2013;1283):e1266. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Pislar A, Kos J. Cysteine cathepsins in neurological disorders. Mol Neurobiol. 2014;49:1017&#x2013;1030. doi: 10.1007/s12035-013-8576-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8576-6</ArticleId><ArticleId IdType="pubmed">24234234</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Riese RJ, Mitchell RN, Villadangos JA, Shi GP, Palmer JT, Karp ER, De Sanctis GT, Ploegh HL, Chapman HA. Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest. 1998;101:2351&#x2013;2363. doi: 10.1172/JCI1158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI1158</ArticleId><ArticleId IdType="pmc">PMC508824</ArticleId><ArticleId IdType="pubmed">9616206</ArticleId></ArticleIdList></Reference><Reference><Citation>Russ J, Liu EY, Wu K, Neal D, Suh E, Irwin DJ, McMillan CT, Harms MB, Cairns NJ, Wood EM, et al. Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier. Acta Neuropathol. 2015;129:39&#x2013;52. doi: 10.1007/s00401-014-1365-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1365-0</ArticleId><ArticleId IdType="pmc">PMC4282973</ArticleId><ArticleId IdType="pubmed">25388784</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmahmann JD, Guell X, Stoodley CJ, Halko MA. The theory and neuroscience of cerebellar cognition. Annu Rev Neurosci. 2019;42:337&#x2013;364. doi: 10.1146/annurev-neuro-070918-050258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-070918-050258</ArticleId><ArticleId IdType="pubmed">30939101</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa C, Golebiewska A, Poovathingal SK, Kaoma T, Pires-Afonso Y, Martina S, Coowar D, Azuaje F, Skupin A, Balling R, et al. Single-cell transcriptomics reveals distinct inflammation-induced microglia signatures. EMBO Rep. 2018 doi: 10.15252/embr.201846171.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201846171</ArticleId><ArticleId IdType="pmc">PMC6216255</ArticleId><ArticleId IdType="pubmed">30206190</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10:661&#x2013;670. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, O'Reilly EJ, Weisskopf MG, Logroscino G, McCullough ML, Thun MJ, Schatzkin A, Kolonel LN, Ascherio A. Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. Arch Neurol. 2011;68:207&#x2013;213. doi: 10.1001/archneurol.2010.367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.367</ArticleId><ArticleId IdType="pmc">PMC3319086</ArticleId><ArticleId IdType="pubmed">21320987</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z, Zinman L, Moreno D, Schymick J, Liang Y, Sato C, Zheng Y, Ghani M, Dib S, Keith J, et al. Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. Am J Hum Genet. 2013;92:981&#x2013;989. doi: 10.1016/j.ajhg.2013.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.04.017</ArticleId><ArticleId IdType="pmc">PMC3675239</ArticleId><ArticleId IdType="pubmed">23731538</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Dilliott AA, Khallaf R, Robinson JF, Hegele RA, Comishen M, Sato C, Tosto G, Reitz C, Mayeux R, et al. Genetic and epigenetic study of an Alzheimer's disease family with monozygotic triplets. Brain J Neurol. 2019;142:3375&#x2013;3381. doi: 10.1093/brain/awz289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz289</ArticleId><ArticleId IdType="pmc">PMC6821163</ArticleId><ArticleId IdType="pubmed">31580390</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Ferrari R, Tartaglia MC, Keith J, Surace EI, Wolf U, Sato C, Grinberg M, Liang Y, Xi Z, et al. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers. Brain. 2018;141:2895&#x2013;2907. doi: 10.1093/brain/awy238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy238</ArticleId><ArticleId IdType="pmc">PMC6158742</ArticleId><ArticleId IdType="pubmed">30252044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, McKeever PM, Xi Z, Moreno D, Sato C, Bergsma T, McGoldrick P, Keith J, Robertson J, Zinman L, et al. DNA methylation age acceleration is associated with ALS age of onset and survival. Acta Neuropathol. 2020;139:943&#x2013;946. doi: 10.1007/s00401-020-02131-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02131-z</ArticleId><ArticleId IdType="pmc">PMC7181538</ArticleId><ArticleId IdType="pubmed">32146547</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Tartaglia MC, Moreno D, Sato C, McKeever P, Weichert A, Keith J, Robertson J, Zinman L, Rogaeva E. DNA methylation age-acceleration is associated with disease duration and age at onset in C9orf72 patients. Acta Neuropathol. 2017;134:271&#x2013;279. doi: 10.1007/s00401-017-1713-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1713-y</ArticleId><ArticleId IdType="pmc">PMC5508035</ArticleId><ArticleId IdType="pubmed">28439722</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Xi Z, Ghani M, Jia P, Pal M, Werynska K, Moreno D, Sato C, Liang Y, Robertson J, et al. Genetic and epigenetic study of ALS-discordant identical twins with double mutations in SOD1 and ARHGEF28. J Neurol Neurosurg Psychiatry. 2016;87:1268&#x2013;1270. doi: 10.1136/jnnp-2016-313592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-313592</ArticleId><ArticleId IdType="pubmed">27154192</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>